Li 2006c.
Methods | Four‐week, randomised study |
Participants | Patients with depression according to CCMD‐III criteria |
Interventions | Sixty patients randomised to fluoxetine or reboxetine Fluoxetine dose range: 4‐8 mg Reboxetine dose range: 20‐40 mg |
Outcomes | Hamilton Depression Rating Scale (HDRS) and Clinical Global Impression (CGI) |
Notes | Waiting for translation from Chinese to English (only abstract available in English) |